Acutaas Chemicals Limited (ACUTAAS) Share Price
NSE · Basic Materials · Specialty Chemicals · ISIN INE00FF01025
Key metrics
- Market Cap
- ₹26,867 Cr
- P/E Ratio
- 93.87
- EPS
- 34.96
- Book Value
- 161.24
- P/B Ratio
- 20.84
- ROE
- 12.02%
- ROCE
- 15.41%
- Debt / Equity
- 0.01
- Net Margin
- 15.87%
- Revenue Growth
- 40.25%
- Profit Growth
- 271.06%
- Dividend Yield
- 0.05%
- 52W High
- ₹3,740.00
- 52W Low
- ₹1,302.00
- Market Cap Band
- large cap
- Face Value
- 5
Ratios computed from the annual results period ending 2025-03-31.
About Acutaas Chemicals Limited
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.
- Headquarters
- Surat, India
- Promoter Holding
- 38.31%
The full Acutaas Chemicals Limited analysis
Create a free account to open the complete ACUTAAS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.